MedicarePartD.guide

A non-government resource built from CMS public data

TASCENSO ODT .5 mg Tablet, Orally Disintegrating

Also known as Fingolimod Lauryl Sulfate. Coverage in Nevada (CMS PDP Region 29).

Not on any stand-alone Part D formulary in Nevada

None of the 10 stand-alone Part D (PDP) plans in CMS PDP Region 29 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →